Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2023-03-29 Management Reports
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
2022年度董事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2022 Annual Board of Directors Work Report" of Changchun High-tech Industry (Group) Co., Ltd. It contains detailed descriptions of the company's operational performance, financial results, project construction, investor relations, board meeting activities, committee reports, independent directors' duties, future development plans, and risk management for the year 2022. The content is comprehensive and covers management's explanation of financial results, business trends, and outlook. It is not a full annual report with complete financial statements but rather a detailed management report focusing on the board's work and company performance over the year. This fits the definition of a Management Reports (MDA) filing, which includes management's detailed explanation of financial results and business trends. The document length (7477 characters) and content depth support this classification rather than a brief announcement or a full annual report (10-K).
2023-03-29 Chinese
北京市康达律师事务所关于公司2022年限制性股票与股票期权激励计划回购注销部分已获授但尚未解除限售限制性股票以及注销部分已获授但尚未行权股票期权相关事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the repurchase and cancellation of restricted stocks and stock options under a 2022 stock incentive plan of Changchun High-tech Industry (Group) Co., Ltd. It details the legal basis, approvals, authorizations, reasons, quantities, and prices related to the repurchase and cancellation. The document is not a financial report, earnings release, or management discussion, but a legal opinion related to stock incentive plan adjustments and share repurchase/cancellation. It is not a simple announcement but a detailed legal opinion letter. This type of document fits best under the category of Regulatory Filings (RNS) as it is a legal compliance document and does not fit other categories like Capital/Financing Update (CAP) or Transaction in Own Shares (POS) which are more about announcements rather than legal opinions. The document length (8098 characters) and content confirm it is not a brief announcement or a report publication announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-03-29 Chinese
关于子公司对外担保的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Changchun High-tech Industry (Group) Co., Ltd. regarding an external guarantee provided by its subsidiary for a loan application. It details the guarantee amount, terms, the involved parties, financial data of the guaranteed company, and board approval. The document is an announcement of a financing-related event (a guarantee for a loan) rather than a financial report or audit. It does not contain financial statements or earnings data but focuses on a capital/financing update related to credit guarantees. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 1809 characters, consistent with an announcement rather than a full report.
2023-03-29 Chinese
2022年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2022 年年度报告摘要" which translates to "2022 Annual Report Summary". It contains detailed financial data for the year 2022, including total assets, net profit, earnings per share, and quarterly financial data. It also includes company business descriptions, product lines, shareholder information, and bond information. The length of the document is over 10,000 characters, indicating it is a substantive report rather than a brief announcement. The content matches the characteristics of an official yearly report covering company activity and full financial performance. Therefore, this document is classified as an Annual Report (10-K). FY 2022
2023-03-29 Chinese
内部控制审计报告
Audit Report / Information Classification · 100% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It is issued by a certified public accounting firm and addresses the effectiveness of the company's internal control over financial reporting as of December 31, 2022. The content includes the auditor's responsibilities, the company's responsibilities, inherent limitations of internal control, and the auditor's opinion on the effectiveness of internal control. The document is a standalone audit report focused on internal control over financial reporting, not a full annual report or other type of filing. The length is 1465 characters, which is consistent with a standalone audit report rather than a full annual report or earnings release. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2022
2023-03-29 Chinese
监事会关于回购注销部分限制性股票及注销部分股票期权的审核意见
Board/Management Information Classification · 90% confidence The document is a supervisory board's audit opinion regarding the repurchase and cancellation of restricted stocks and stock options. It discusses compliance with relevant laws and company regulations, approval by the board and supervisory meetings, and the impact on shareholders. This is a report on internal governance and supervisory review related to stock incentive plans, not a full financial report or announcement of voting results. It does not contain financial statements or earnings data, nor is it a notice of voting results or a proxy solicitation. The content fits best under Board/Management Information (MANG) as it relates to management decisions and board/supervisory opinions on stock incentive matters.
2023-03-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.